ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    To determine the hematological findings & coagulation profile in patients with bleeding manifestations


    Dr Hemlata Bamoriya Dr. Geeta Devi Dr. Gautam Chandrakoshi
    JCDR. 2021: 3518-3522

    Abstract

    The aim of study is to determine the hematological findings & coagulation profile in patients with bleeding manifestations. Bleeding time is a blood test that looks at how fast small blood vessels close to stop bleeding. This test helps diagnose bleeding problems. Pre-requisites-Certain medications including dextran, nonsteroidal anti-inflammatory drugs (NSAIDs), and salicylates (including aspirin) may change the test results. So the patient should be told to stop taking these medicines if any, a few days before the test. Result: The most prevalent hematological disorder is found to be Idiopathic thrombocytopenic purpura (23%), aplastic anemia (14%), Systemic causes (11%) while Myelodysplastic syndromes & Hemophilia have equal prevalence rate (7%). Among the bleeding disorders platelet disorders (74%) are more common than coagulation disorders (15%). Inherited bleeding disorders involve males (17%, n=104) more commonly than females (6%, n=96). However statistically no gender association could be obtained in inherited bleeding disorders as P = 0.125 (P > 0.05). Conclusion: Study shows the highest prevalence of bleeding disorders that is 27% in the age group of 11-20 years while lowest 5% above 60 years of age. Males are found to be affected slightly more commonly (52%) than females (48%). The most prevalent hematological disorder is Idiopathic thrombocytopenic purpura (23%) followed by aplastic anemia (14%), Systemic causes (11%) Myelodysplastic syndromes (7%). & Hemophilia (7%). Of all the bleeding disorders, platelet disorders (74%) are more common than coagulation disorders (15%).

    Description

    » PDF

    Volume & Issue

    Volume 12 Issue 3

    Keywords